The comparison of safety and availability between Nalbuphine and Sufentanil in laparoscopic cholecystectomy: a prospective randomized controlled trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
INTERVENTION: 1:nalbuphine 0.3mg/kg;2:sufentanil 0.3µg/kg; CONDITION: Gallstones, chronic cholecystitis, gallbladder polyp PRIMARY OUTCOME: drug side effects; SECONDARY OUTCOME: Visual Analogue Scale/Score;Additional analgesic requirements;First time out of bed;Quality of recovery score‐15; INCLUSION CRITERIA: 1. age between 18 and 75 years old; 2. undergoing laparoscopic cholecystectomy; 3. ASA I II; 4. BMI<30; 5. the main organ functions are normal; 6. sign informed consent.
Epistemonikos ID: 559581164a1b20a82e0044518d4e76060299cf4d
First added on: Aug 24, 2024